Emergency Contraception Global Market Report 2026

Emergency contraception is a method employed to prevent pregnancy following unprotected sexual intercourse or contraceptive failure. It usually involves high-dose hormonal pills or the placement of a copper intrauterine device. Its effectiveness is greatest when used as soon as possible after the event, ideally within 72 hours.

The key product types of emergency contraception include levonorgestrel, ulipristal acetate, mifepristone, and other variants. Levonorgestrel is a hormonal formulation used to prevent pregnancy after unprotected intercourse or contraceptive failure. Dosage forms include tablets, injections, and others, administered to adolescents and adults. Distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and others, serving hospitals, clinics, homecare, and other end users.

Tariffs on imported hormonal pills, copper IUD components, and raw materials are impacting the emergency contraception market by increasing costs for manufacturers and distributors, particularly affecting levonorgestrel, ulipristal acetate, and mifepristone products. Regions such as North America, Europe, and Asia-Pacific that rely on imported pharmaceuticals and device components are most affected. While tariffs increase procurement costs, they also encourage local production, promote domestic manufacturing of contraceptive products, and foster innovation in affordable and diversified formulations, benefiting regional supply chains.

The emergency contraception market research report is one of a series of new reports from The Business Research Company that provides emergency contraception market statistics, including emergency contraception industry global market size, regional shares, competitors with a emergency contraception market share, detailed emergency contraception market segments, market trends and opportunities, and any further data you may need to thrive in the emergency contraception industry. This emergency contraception market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emergency contraception market size has grown strongly in recent years. It will grow from $1.55 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing awareness of emergency contraception, rising contraceptive failure rates, expansion of retail pharmacy networks, growing demand for hormonal contraceptives, regulatory approvals for emergency contraceptive pills.

The emergency contraception market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing adoption of online pharmacy platforms, growing demand for homecare delivery services, expansion of age-specific awareness programs, rising preference for non-hormonal and herbal alternatives, introduction of high-dose and multi-formulation products. Major trends in the forecast period include increasing availability of over-the-counter emergency contraceptives, rising adoption of online pharmacies and home delivery services, growing focus on adolescent and adult awareness programs, expansion of high-dose and multi-formulation options, rising integration of copper intrauterine devices and non-hormonal methods.

The increasing rates of unprotected intercourse are expected to drive the growth of the emergency contraception market going forward. Unprotected intercourse refers to sexual activity conducted without using any form of barrier contraception, such as condoms, or other effective birth control methods, leaving participants susceptible to unintended pregnancies and sexually transmitted infections. The incidence of unprotected intercourse is rising due to declining condom use and inconsistent adoption of other contraceptive methods among sexually active individuals, particularly young adults and adolescents, which increases the likelihood of unprotected sexual encounters. Emergency contraception serves as an important safety measure following unprotected intercourse by preventing unintended pregnancies, thereby directly addressing the consequences of missed or no contraception and reducing immediate risks associated with unprotected sexual activity. For instance, according to the 2023 National Youth Risk Behavior Survey by the Centers for Disease Control and Prevention, a US-based government agency, in a 2023 survey of U.S. high school students, 32% reported having had sexual intercourse at least once, and 48% indicated they did not use a condom during their most recent sexual encounter. Therefore, the rising rates of unprotected intercourse are propelling the growth of the emergency contraception market.

Key companies operating in the emergency contraception market are focusing on developing innovative products such as over-the-counter emergency contraceptives to increase accessibility and provide rapid, effective pregnancy prevention. Over-the-counter emergency contraceptives are oral pills containing hormones such as levonorgestrel that can be purchased without a prescription and help prevent pregnancy by delaying ovulation or fertilization when taken shortly after unprotected sex. For example, in August 2024, Versea Health Inc., a US-based healthcare company specializing in diagnostics and consumer health solutions, launched Empowered Choice, a U.S. Food and Drug Administration-approved over-the-counter emergency contraceptive aimed at expanding accessible options in mainstream retail and online channels. The launch included nationwide distribution partnerships with major pharmacies and e-commerce platforms, combined with a comprehensive educational campaign to raise awareness about emergency contraception options, proper usage, and timing for optimal effectiveness. The initiative sought to reach a wider audience, reduce stigma around emergency contraception, and ensure that individuals could obtain the product quickly and discreetly. The product features a simple oral levonorgestrel formulation that ensures effective emergency pregnancy prevention, can be used without a prescription, and provides individuals with increased autonomy and flexibility in reproductive health decision-making.

In March 2023, Curae Pharma360 Inc., a US-based pharmaceutical company specializing in over-the-counter (OTC) emergency contraceptives, partnered with Direct Relief to provide OTC emergency contraception to underserved women. Through this collaboration, Curae Pharma360 Inc. and Direct Relief aim to enhance equitable access to essential medicines, deliver timely reproductive healthcare solutions, and support community health initiatives for women in need. Direct Relief is a US-based nonprofit organization offering medical assistance and disaster relief to improve health outcomes.

Major companies operating in the emergency contraception market are Pfizer Inc.; Bayer Aktiengesellschaft, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Amneal Pharmaceuticals Inc., Lupin Limited, Gedeon Richter Plc, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Mankind Pharma Limited, Piramal Pharma Limited, CooperSurgical Inc., HLL Lifecare Limited, Zhejiang Xianju Pharmaceutical Co. Ltd., AdvaCare Pharma, Afaxys Inc., Syzygy Healthcare Solutions, Foundation Consumer Healthcare, Shanghai Dahua Pharmaceutical Co. Ltd.

North America was the largest region in the emergency contraception market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emergency contraception market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the emergency contraception market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The emergency contraception market consists of sales of combined hormonal emergency contraceptive pills, copper intrauterine devices (IUDs), over-the-counter emergency contraceptive products, and emergency contraceptive pill kits. Values in this market are "factory gate" values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services such as regulatory compliance support, packaging, labeling, and pharmacovigilance services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emergency Contraception Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses emergency contraception market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emergency contraception ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The emergency contraception market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Levonorgestrel; Ulipristal Acetate; Mifepristone; Other Product Types
• 2) By Dosage Form: Tablets; Injections; Other Dosage Forms
• 3) By Age Group: Adolescents; Adults
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 5) By End-User: Hospitals; Clinics; Homecare; Other End Users
• Subsegments:
• 1) By Levonorgestrel: Single Dose Tablets; Two Dose Tablets; Over The Counter Formulations; Prescription Based Formulations
• 2) By Ulipristal Acetate: Single Dose Tablets; Prescription Based Tablets; High Dose Formulations; Low Dose Formulations
• 3) By Mifepristone: Low Dose Emergency Use; Combination Regimen Formulations; Prescription Based Tablets; Clinical Setting Formulations
• 4) By Other Product Types: Copper Intrauterine Devices; Combined Hormonal Regimens; Non Hormonal Methods; Herbal Based Formulations
• Companies Mentioned: Pfizer Inc.; Bayer Aktiengesellschaft; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Perrigo Company plc; Cipla Limited; Amneal Pharmaceuticals Inc.; Lupin Limited; Gedeon Richter Plc; Zydus Lifesciences Limited; Alkem Laboratories Ltd.; Glenmark Pharmaceuticals Ltd.; Mankind Pharma Limited; Piramal Pharma Limited; CooperSurgical Inc.; HLL Lifecare Limited; Zhejiang Xianju Pharmaceutical Co. Ltd.; AdvaCare Pharma; Afaxys Inc.; Syzygy Healthcare Solutions; Foundation Consumer Healthcare; Shanghai Dahua Pharmaceutical Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.